97 related articles for article (PubMed ID: 32706340)
21. Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk.
Wang H; Yang Z; Zhang H
Breast Cancer Res Treat; 2013 Jan; 137(2):511-22. PubMed ID: 23184080
[TBL] [Abstract][Full Text] [Related]
22. Low penetrance alleles as risk modifiers in familial and sporadic breast cancer.
Esteban Cardeñosa E; de Juan Jiménez I; Palanca Suela S; Chirivella González I; Segura Huerta A; Santaballa Beltran A; Casals El Busto M; Barragán González E; Fuster Lluch O; Bermúdez Edo J; Bolufer Gilabert P
Fam Cancer; 2012 Dec; 11(4):629-36. PubMed ID: 22926736
[TBL] [Abstract][Full Text] [Related]
23. [Association of FGFR2 gene polymorphism with estrogen receptor positive breast cancer detected by fluorescent quantitative PCR].
Ren L; Zhang B; Cao XC; Chen Y; Ge J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Aug; 27(4):445-8. PubMed ID: 20677155
[TBL] [Abstract][Full Text] [Related]
24. Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10.
Huijts PE; van Dongen M; de Goeij MC; van Moolenbroek AJ; Blanken F; Vreeswijk MP; de Kruijf EM; Mesker WE; van Zwet EW; Tollenaar RA; Smit VT; van Asperen CJ; Devilee P
Breast Cancer Res; 2011 Jul; 13(4):R72. PubMed ID: 21767389
[TBL] [Abstract][Full Text] [Related]
25. Association of FGFR2 gene polymorphisms with the risk of breast cancer in population of West Siberia.
Boyarskikh UA; Zarubina NA; Biltueva JA; Sinkina TV; Voronina EN; Lazarev AF; Petrova VD; Aulchenko YS; Filipenko ML
Eur J Hum Genet; 2009 Dec; 17(12):1688-91. PubMed ID: 19536173
[TBL] [Abstract][Full Text] [Related]
26. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
[TBL] [Abstract][Full Text] [Related]
27. Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis.
Zhang J; Qiu LX; Wang ZH; Leaw SJ; Wang BY; Wang JL; Cao ZG; Gao JL; Hu XC
Breast Cancer Res Treat; 2010 Nov; 124(2):419-24. PubMed ID: 20300826
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of FGFR2 gene polymorphism in women with breast cancer.
Salehi Z; Afzali S; Shabanipour S; Rahimi A
Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):94-7. PubMed ID: 26025410
[TBL] [Abstract][Full Text] [Related]
29. Does
Gedvilaite G; Vilkeviciute A; Kriauciuniene L; Asmoniene V; Liutkeviciene R
Ophthalmic Genet; 2019 Jun; 40(3):219-226. PubMed ID: 31199170
[No Abstract] [Full Text] [Related]
30. Smoking and FGFR2 rs2981582 variant independently modulate male breast cancer survival: A population-based study in Tuscany, Italy.
Zanna I; Silvestri V; Palli D; Magrini A; Rizzolo P; Saieva C; Zelli V; Bendinelli B; Vezzosi V; Valentini V; Bianchi S; Ottini L; Masala G
Breast; 2018 Aug; 40():85-91. PubMed ID: 29709729
[TBL] [Abstract][Full Text] [Related]
31. FGFR2 genetic variants in women with breast cancer.
Dix-Peek T; Dickens C; Augustine TN; Phakathi BP; Van Den Berg EJ; Joffe M; Ayeni OA; Cubasch H; Nietz S; Mathew CG; Hayat M; Neugut AI; Jacobson JS; Ruff P; Duarte RAB
Mol Med Rep; 2023 Dec; 28(6):. PubMed ID: 37830168
[TBL] [Abstract][Full Text] [Related]
32. Association of
Glebauskiene B; Vilkeviciute A; Liutkeviciene R; Jakstiene S; Kriauciuniene L; Zemaitiene R; Zaliuniene D
Oncol Lett; 2017 May; 13(5):3087-3099. PubMed ID: 28521414
[TBL] [Abstract][Full Text] [Related]
33. Association of single nucleotide polymorphisms in FGF-RAS/MAP signalling cascade with breast cancer susceptibility.
Dankova Z; Zubor P; Grendar M; Kapinova A; Zelinova K; Jagelkova M; Gondova A; Dokus K; Kalman M; Lasabova Z; Danko J
Gen Physiol Biophys; 2017 Dec; 36(5):565-572. PubMed ID: 29372690
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor receptor 2 gene (
AlRaddadi RIR; Alamri RJN; Shebli WTY; Fallatah EIY; Alhujaily AS; Mohamed HS; Alotibi MKH
Saudi J Biol Sci; 2021 Nov; 28(11):6112-6115. PubMed ID: 34759736
[TBL] [Abstract][Full Text] [Related]
35. Involvement of fibroblast growth factor receptor genes in benign prostate hyperplasia in a Korean population.
Park HJ; Kim SK; Kim JW; Lee SH; Yoo KH; Chung JH
Dis Markers; 2013; 35(6):869-75. PubMed ID: 24385678
[TBL] [Abstract][Full Text] [Related]
36. Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk.
Zhao ZZ; Pollock PM; Thomas S; Treloar SA; Nyholt DR; Montgomery GW
Hum Reprod; 2008 Jul; 23(7):1661-8. PubMed ID: 18285324
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer.
Lin CY; Ho CM; Bau DT; Yang SF; Liu SH; Lin PH; Lin TH; Tien N; Shih MC; Lu JJ
Anticancer Res; 2012 Feb; 32(2):475-82. PubMed ID: 22287734
[TBL] [Abstract][Full Text] [Related]
38. Case-control study on the fibroblast growth factor receptor 2 gene polymorphisms associated with breast cancer in chinese han women.
Liu CL; Hu XP; Guo WD; Yang L; Dang J; Jiao HY
J Breast Cancer; 2013 Dec; 16(4):366-71. PubMed ID: 24454457
[TBL] [Abstract][Full Text] [Related]
39. Variants of FGFR2 and their associations with breast cancer risk: a HUGE systematic review and meta-analysis.
Cui F; Wu D; Wang W; He X; Wang M
Breast Cancer Res Treat; 2016 Jan; 155(2):313-35. PubMed ID: 26728143
[TBL] [Abstract][Full Text] [Related]
40. FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations.
Raskin L; Pinchev M; Arad C; Lejbkowicz F; Tamir A; Rennert HS; Rennert G; Gruber SB
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1060-5. PubMed ID: 18483326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
